[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617392":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":32,"responsibleParty":51,"collaborators":20,"id":53,"slug":20,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":20,"enrollmentInfo":62,"targetDuration":20,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":80,"whyStopped":20,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Mario Negri Institute for Pharmacological Research","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients","EXPERIMENTAL","Patients undergoing HD with a functioning native AVF",[13],"Device: AVF MONITOR",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","AVF MONITOR","Wearable non-invasive device consisting in an electronic platform that can acquire acoustic data by means of an analog microphone.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Giuseppe Remuzzi, M.D.","Istituto Di Ricerche Farmacologiche Mario Negri","STUDY_DIRECTOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Michela Bozzetto","CONTACT","+3903545351","michela.bozzetto@marionegri.it",[33],{"facility":34,"status":20,"city":35,"state":36,"zip":20,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"ASST HPG23 - Unità di Nefrologia","Bergamo","BG","Italy",{"type":39,"coordinates":40},"Point",[41,42],9.66721,45.69601,{"lat":42,"lon":41},[45,49],{"name":46,"role":29,"phone":47,"phoneExt":20,"email":48},"Simona Zerbi, M.D.","+39035267111","szerbi@asst-pg23.it",{"name":46,"role":50,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"type":52,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100617392",false,"NCT07318025","AVF-MONITOR POC Proof-of-concept Study","AVF-MONITOR: a New Wearable Device for Vascular Access Monitoring in Hemodialysis Patients - Proof-of-concept Study","AVFMONITOR POC","Inclusion Criteria:\n\n* Provision of informed consent prior to any study specific procedures.\n* Female and\u002For male aged ≥ 18.\n* Patients undergoing HD with a mature and functioning native AVF.\n\nExclusion Criteria:\n\n* Patients with a history of complications related to the AVF in use.\n* Patients who use a graft or catheter to perform HD.\n* Patients with reduced life expectancy (less than 1 year).","ALL","18 Years",{"count":63,"type":64},6,"ESTIMATED","INTERVENTIONAL",[67],"NA","This is a proof-of-concept single-centre prospective longitudinal interventional study performed in AVF patients under HD treatment at the Nephrology and Dialysis Department of the ASST-Papa Giovanni XXIII (Bergamo, Italy), involving the recording of AVF sounds by the AVF-MONITOR wearable prototype device.\n\nParticipants will undergo a screening and enrollment visit, then follow-up visits for AVF sounds registration will be conducted once a week for all participants, prior to dialysis session, over a period of 8 weeks.",[70],"Hemodyalysis",[72,73,74,75,76,77,78,79],"arteriovenous fistula","hemodialysis","vascular access","monitoring","sound recording","proof-of-concept study","prototype device","vascular stenosis","NOT_YET_RECRUITING","2026-01-12",{"date":83,"type":84},"2026-01-14","ACTUAL",{"date":86,"type":64},"2026-03",{"date":88,"type":64},"2026-09",{"name":5,"class":6},1]